Cartesian Therapeutics, Inc. (NASDAQ:RNAC) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carrie S. Cox Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); Organon & Co. (Executive Board Chair · Since at least Jun 2, 2021); Texas Instruments Incorporated (Director · Since at least Jul 28, 2015); electroCore, Inc. (Director · Jun 21, 2018 – Jun 7, 2019 · Past); Cardinal Health, Inc. (Director · Nov 4, 2015 – Nov 9, 2022 · Past); Celgene Corporation (Director · Jul 1, 2015 – Nov 20, 2019 · Past) | Director · Nov 20, 2019 – Jan 2, 2025 · Past |
| Nishan M DeSilva Other companies: Ligand Pharmaceuticals Incorporated (VP, Finance & Strategy and CFO · Feb 9, 2012 – May 12, 2015 · Past); Talon Therapeutics Inc (Director · Apr 1, 2011 – Apr 1, 2011 · Past); Allos Therapeutics Inc (Director · Jun 22, 2010 – Dec 13, 2011 · Past) | Director · Since at least Jun 23, 2021 |
| Bradford D Dahms Other companies: Jade Biosciences, Inc. (Chief Financial Officer · Since at least Jul 14, 2025); Theseus Pharmaceuticals Inc (President and CFO · Oct 6, 2021 – Feb 14, 2024 · Past) | Chief Financial Officer · Sep 3, 2019 – Jan 4, 2021 · Past |
| John Leaman Other companies: Traws Pharma, Inc. (Director · Since at least Oct 1, 2025); Impel Neuropharma Inc (Chief Fin. & Business Officer · Apr 22, 2021 – Jan 26, 2022 · Past) | CFO, Treas. & Hd Corp Strategy · Oct 26, 2017 – Jun 15, 2018 · Past |
| Carsten Brunn Other companies: Surface Oncology Inc (Director · Jun 28, 2022 – Jun 28, 2022 · Past) | President, Chief Executive Officer, and Chairman, Board of Directors · Since at least Dec 1, 2018 |
| Göran Ando Other companies: EyePoint, Inc. (Non-Executive Chairman · Since at least Jun 25, 2018) | Director · Apr 24, 2020 – Jan 2, 2023 · Past |
| Kemal Malik Other companies: Acceleron Pharma Inc (Director · Jan 2, 2020 – Nov 19, 2021 · Past) | Director · Since at least Jul 1, 2024 |
| Kevin Tan Other companies: Solid Biosciences Inc. (CFO & Treasurer · Since at least Jan 9, 2023) | Chief Financial Officer · Sep 20, 2021 – Jan 3, 2022 · Past |
| Stephen Smolinski Other companies: Avalo Therapeutics, Inc. (Chief Commercial Officer · Jan 3, 2022 – Jan 4, 2022 · Past) | Chief Commercial Officer · Oct 26, 2017 – Jan 2, 2020 · Past |
| Timothy Barabe Other companies: Heartflow, Inc. (Director · Since at least Aug 7, 2025) | Director · Since at least May 9, 2022 |
| Adrian Bot | Director · Since at least Dec 16, 2025 |
| Ann K Donohue | VP Finance · May 7, 2019 – May 27, 2021 · Past |
| Aymeric Sallin | Director · Jun 21, 2016 – Jan 2, 2024 · Past |
| Blaine Davis | Chief Financial Officer · Since at least Nov 13, 2023 |
| Christopher M Jewell | Chief Scientific Officer · Nov 13, 2023 – Jan 10, 2025 · Past |
| Emily English | Chief Operations Officer · Since at least Apr 9, 2024 |
| Leysan Shaydullina | Director · Jun 21, 2016 – Jun 21, 2016 · Past |
| Matthew Bartholomae | General Counsel, Secretary · Since at least Nov 5, 2026 |
| Metin Kurtoglu | Chief Technology Officer · Nov 13, 2023 – Jan 3, 2025 · Past |
| Michael Singer | Director · Since at least Nov 13, 2023 |
| Nishan de Silva | Director · Since at least Nov 5, 2026 |
| Patrick Zenner | Director · Since at least Oct 30, 2025 |
| Peter Keller | Chief Business Officer · Jun 21, 2016 – Jul 7, 2017 · Past |
| Peter Traber | Head of Research and Development · Since at least May 26, 2026 |
| Takashi Kei Kishimoto | Chief Scientific Officer · Jun 21, 2016 – May 30, 2023 · Past |
| Timothy Springer | Director · Since at least Nov 5, 2026 |